Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Staar Surgical Company (STAA)

Staar Surgical Company (STAA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,347,502
  • Shares Outstanding, K 45,806
  • Annual Sales, $ 150,190 K
  • Annual Income, $ 14,050 K
  • 60-Month Beta 1.33
  • Price/Sales 22.75
  • Price/Cash Flow 130.63
  • Price/Book 19.44
Trade STAA with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 0.09
  • Number of Estimates 2
  • High Estimate 0.09
  • Low Estimate 0.08
  • Prior Year 0.12
  • Growth Rate Est. (year over year) -25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
55.01 +35.12%
on 10/02/20
75.24 -1.21%
on 10/29/20
+17.97 (+31.88%)
since 09/29/20
3-Month
45.47 +63.47%
on 08/28/20
75.24 -1.21%
on 10/29/20
+17.75 (+31.37%)
since 07/29/20
52-Week
23.20 +220.39%
on 03/16/20
75.24 -1.21%
on 10/29/20
+45.72 (+159.80%)
since 10/29/19

Most Recent Stories

More News
STAAR Surgical to Report Third Quarter Results on November 4, 2020

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results...

STAA : 74.33 (+1.71%)
37.3% Return Seen to Date on SmarTrend Staar Surgical Call (STAA)

SmarTrend identified an Uptrend for Staar Surgical (NASDAQ:STAA) on September 3rd, 2020 at $51.83. In approximately 2 months, Staar Surgical has returned 37.31% as of today's recent price of $71.17.

STAA : 74.33 (+1.71%)
Lawsuits Filed Against STAA, PLAN and RCL - Jakubowitz Law Pursues Shareholders Claims

NEW YORK, NY / ACCESSWIRE / October 19, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who...

STAA : 74.33 (+1.71%)
PLAN : 56.71 (+1.39%)
RCL : 53.83 (+1.34%)
STAA FINAL DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, Reminds STAAR Surgical Company Investors of Important October 19 Deadline in Securities Class Action - STAA

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of STAAR Surgical Company (NASDAQ: STAA) between February 26, 2020 and August 10, 2020, inclusive (the "Class Period")...

STAA : 74.33 (+1.71%)
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of STAA, AYX and PLAN

NEW YORK, NY / ACCESSWIRE / October 19, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate...

STAA : 74.33 (+1.71%)
AYX : 134.45 (-1.19%)
PLAN : 56.71 (+1.39%)
STAA FINAL DEADLINE: Bronstein, Gewirtz & Grossman, LLC Reminds STAAR Surgical Company of Class Action and Encourages Shareholders to Contact the Firm

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) and certain...

STAA : 74.33 (+1.71%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Staar Surgical Company of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 19, 2020 - STAA

New York, New York--(Newsfile Corp. - October 19, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:

STAA : 74.33 (+1.71%)
Rosen, Top Ranked Global Counsel, Reminds STAAR Surgical Company Investors of Important October 19 Deadline in Securities Class Action - STAA

New York, New York--(Newsfile Corp. - October 19, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of STAAR Surgical Company (NASDAQ: STAA) between February...

STAA : 74.33 (+1.71%)
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against STAAR Surgical Company and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - October 19, 2020) - , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against STAAR Surgical Company ("STAAR" or...

STAA : 74.33 (+1.71%)
CLASS ACTION UPDATE for STAA, BLNK and PLAN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / October 19, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders...

STAA : 74.33 (+1.71%)
BLNK : 8.03 (+7.64%)
PLAN : 56.71 (+1.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.

See More

Key Turning Points

2nd Resistance Point 76.62
1st Resistance Point 75.47
Last Price 74.33
1st Support Level 72.95
2nd Support Level 71.58

See More

52-Week High 75.24
Last Price 74.33
Fibonacci 61.8% 55.36
Fibonacci 50% 49.22
Fibonacci 38.2% 43.08
52-Week Low 23.20

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar